ChromaDexÂ® Announces First Patent Issued For Pterostilbene, The Novel Ingredient In Its BluScienceâ¿¢ Line Of Dietary Products
IRVINE, Calif., April 5, 2012 /PRNewswire/ -- The U.S. Patent and Trademark Office has granted patent #8,133,917 pertaining to the ingredient pterostilbene, which is licensed exclusively to ChromaDex Corp. (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of BluScience ( www.bluscience.com), its new line of dietary supplements.
This is the first ChromaDex-licensed patent issued for pterostilbene, while several more patents are pending.
The three key claims of the pterostilbene patent, which encompass both the nutraceutical market and the pharmaceuticals market, relate to:
- A method of lowering lipid levels and to treat or reduce the risk of dyslipidemias in an individual through an effective amount of edible nutraceutical composition consisting of isolated or chemically-synthesized pterostilbene and a nutraceutically acceptable carrier;
- A method of lowering lipid levels in an individual through an effective amount of edible pharmaceutical composition consisting of isolated or chemically-synthesized pterostilbene and a pharmaceutically acceptable carrier; and
- A method to treat or reduce the risk of dyslipidemias in an individual at risk of cardiovascular disease through an effective amount of edible pharmaceutical composition consisting of isolated or chemically-synthesized pterostilbene and a pharmaceutically acceptable carrier.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV